With a rise in precision medicines, high value shipments and emergingshipping routes, global biopharma industry spending on temperaturecontrolled products is expected to reach $15.7 billion in 2019.1 To ensure that companies are able to navigate this new product landscape and complex routes in a cost efficient and effective way, they must rely on specialized and trusted partners.

In this report, Pharma IQ explores how these trends will affect temperature control and logistics spending in the next 12 to 24 months. All the findings from our recent survey are presented and analysed below.